{"url_path":"/sec/ebs/proxy/2026-04-27/000119312526182326","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1367644/0001193125-26-182326-index.html","accession_number":"0001193125-26-182326","cik":"0001367644","ticker":"EBS","issuer_name":"Emergent BioSolutions Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1367644/0001193125-26-182326-index.html","primary_entity_key":"0001367644","primary_entity_name":"Emergent BioSolutions Inc."},"word_count":177,"has_tables":true,"body_markdown":"DEFA14A\n1\nd109259ddefa14a.htm\nDEFA14A\n\nDEFA14A\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n**SCHEDULE 14A**\n\n**Proxy\nStatement Pursuant to Section 14(a) of the**\n\n**Securities Exchange Act of 1934**\n\n**(Amendment No. )**\n\nFiled by the Registrant ☒\n\nFiled by a Party other\nthan the Registrant ☐\n\nCheck the appropriate box:\n\n☐\n\nPreliminary Proxy Statement\n\n☐\n\n**Confidential, for Use of the Commission Only (as permitted by Rule\n14a-6(e)(2))**\n\n☐\n\nDefinitive Proxy Statement\n\n☒\n\nDefinitive Additional Materials\n\n☐\n\nSoliciting Material under §240.14a-12\n\n**Emergent BioSolutions Inc.**\n\n**(Name of Registrant as Specified In Its Charter)**\n\n**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)**\n\nPayment of Filing Fee (Check the appropriate box):\n\n☒\n\nNo fee required.\n\n☐\n\nFee paid previously with preliminary materials.\n\n☐\n\nFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules\n14a-6(i)(1) and 0-11.\n\nOn April 27, 2026, Emergent BioSolutions Inc. published the following information on LinkedIn and X.\n\n**LinkedIn/X**\n\nApril 27, 2026\n\nJoin us Wednesday at 9:00 a.m. Eastern Time for Emergent’s virtual annual meeting of stockholders via this link:\nwww.virtualshareholdermeeting.com/EBS2026."}